Skip to content
BY 4.0 license Open Access Published by De Gruyter December 19, 2022

The usefulness of implementing minimum retest intervals in reducing inappropriate laboratory test requests in a Dutch hospital

  • Anneroos W. Boerman , Muhammad Al-Dulaimy , Yvonne C. Bandt , Prabath W.B. Nanayakkara and Robert de Jonge EMAIL logo

Abstract

Objectives

Inappropriate use of laboratory testing remains a challenging problem worldwide. Minimum retest intervals (MRI) are used to reduce inappropriate laboratory testing. However, their effectiveness and the usefulness in reducing inappropriate laboratory testing is still a matter of debate. The aim of this study was to evaluate the effectiveness of broadly implemented MRIs as a means of reducing inappropriate laboratory test requests.

Methods

We performed a retrospective study in a general care and teaching hospital in the Netherlands, where MRI alerts have been implemented as standard care since June 7th 2017. Clinical chemistry test orders in adult internal medicine patients placed between July 13th 2017 and December 31st 2019 were included. The primary outcome was the effectiveness of MRIs, expressed as percentages of tests ordered and barred as a result of MRIs.

Results

Of a total of 218,511 test requests, 4,159 (1.90%) got an MRI alert. These MRIs were overruled by physicians in 21.76% of the cases. As a result of implementing MRIs, 3,254 (1.49%) tests were barred. The financial savings for the department of internal medicine directly related to the included barred laboratory tests during this period were 11,880 euros on a total amount of 636,598 euros for all performed tests.

Conclusions

Only a small proportion of laboratory tests are barred after implementation of MRIs, with a limited impact on the annual costs. However, MRIs provide a continuous reminder to focus on appropriate testing and the effectiveness of MRIs is potentially higher than described in this study.

Introduction

Over the past decades, a rise in healthcare costs have been observed and international campaigns have been launched to discourage low-value care. Although in vitro diagnostics (IVD) only accounts for a maximum of 2% of the total health care budget worldwide, laboratory testing represents the largest volume of diagnostics in current use, and an estimated overuse of approximately 20% has been described [1, 2]. Apart from the financial consequences, a decrease in unnecessary testing would be more patient friendly and would lower the risk of false positive results and additional potentially harmful downturn diagnostics [3]. Despite different campaigns and studies to reduce inappropriate use of laboratory testing, it is still a challenging problem. We recently demonstrated in the RODEO project that a reduction of 11% in laboratory test volume could be achieved by using a combination of different interventions, such as education, feedback and modifications in order entry systems such as minimum retest intervals (MRI) [4]. However, the effect of the individual components of these combined interventions on this reduction is not clear. In the primary care setting, education and computerized physician order entry (CPOE) strategies such as order sets and reflex testing seem most effective while feed-back reports and cost display as single interventions have minimal effects [5].

A MRI is an intervention to reduce inappropriate laboratory retesting and can be implemented as a CPOE intervention if a local laboratory system can provide this facility. A MRI is a defined time period in which a test cannot be repeated, the test order will be blocked. Retesting in this time interval is considered to have limited clinical value and should therefore be avoided unless a physician has specific reasons for overruling the MRI. Besides MRI, other terms used to describe this intervention include frequency filtering, spare periods, redundancy checks, electronic gatekeeping and demand management in general [4, 6], [7], [8]. Choosing the right time interval is important in the prevention of missing clinical relevant results due to too restrictive MRIs, and still let the MRI be effective in blocking inappropriate repeated tests. There is no international guideline on standard time periods for MRIs, but The Association for Clinical Biochemistry and Laboratory Medicine has published recommendations for the use of MRIs in clinical biochemistry and these recommendations have frequently been used in previous studies [9], [10], [11].

The effectiveness of broadly implemented MRIs to reduce inappropriate repeat testing is still unclear. A recent review described, based on 31 identified studies between 2000 and 2020, a cancellation of 10.6% of the test requests after MRI implementation [11]. However, these studies have described this intervention for a variety of laboratory tests with different time intervals and mostly in a limited number of the laboratory tests. An earlier study in the Netherlands reported a slighter effect where the proportion of barred tests was only 0.56% [7].

The aim of this study is to evaluate the effectiveness of broadly implemented MRIs to reduce inappropriate laboratory test requests, after implementation in a general care hospital in the Netherlands as a part of combination of interventions.

Materials and methods

Study setting

We performed a retrospective study at Zaans Medical Center, a 318-bed general care and Dutch teaching hospital with approximately 11,000 admissions and 200,000 outpatient visits annually. The clinical chemistry laboratory provides tests in all fields of laboratory diagnostics, except for microbiological, serological and auto-immunological testing. The laboratory performs tests for patients of the emergency department and both in- and outpatients in all other departments. The study protocol was assessed by the local medical Ethics Review Committee and an official approval of this study was not required as the Medical Research Involving Human Subjects Act did not apply (IRB number IRB00002991; case 2020.0716). The requirement for informed consent was waived.

Implementation of minimum retest intervals

MRIs were implemented in the electronic laboratory information and management system (LIMS) system on June 7th 2017, as part of the RODEO project to reduce unnecessary laboratory testing. In the RODEO project, MRIs were described as redundancy checks. Other interventions during this previous study were focused on creating awareness using education and feedback [4]. In this hospital, LIMS is connected with the Electronic Health Records (EHR) and test results are visible for physicians in the EHR. MRI alerts were generated automatically and the subsequent blockage of test orders was implemented as an automatic process. If a test was blocked due to a MRI, this was reported as a result in the EHR of the patient and visible for the physician. Only by making a phone call to the laboratory, a physician could overrule the MRI and prevent a blockage of the ordered test. Before implementing the MRIs, the time period of a MRI was defined by a medical specialist based on clinical experience, medical knowledge and consensus with other members of the medical staff. First, the MRIs were implemented at the department of internal medicine. Then, it was expanded to other departments of the hospital in different phases. In the first month after implementation, the time period of several MRIs was adjusted after feedback from the medical staff. Hereafter, MRIs were only changed as an exception based on departments’ requests. All MRIs which were active between July 13th 2017 and December 31st 2019 at the internal medicine department were included. MRIs implemented or changed after July 13th 2017 or from other departments were excluded from analysis. Table 1 presents the MRIs as implemented at the department of internal medicine.

Table 1:

Time period of minimum retest intervals (MRIs) implemented in inpatient and outpatient clinics, number of requested tests, blocked tests due to MRI alerts, total number of MRI alerts, overruled MRI alerts, price of laboratory test, total cost savings of blocked tests and total costs of performed tests. 

Test Time period MRI, days Total number of requested tests Requested tests Total number of MRI alerts MRI alerts Price of testa Total costs € tests blocked/€ tests performed
Inpatient Outpatient Performed n (% of requested) Blocked n (% of requested) Honored n (% of alerts) Overruled n (% of alerts)
Vitamin B12 30 30 3,074 3,019 (98.21%) 55 (1.79%) 57 55 (96.49%) 2 (3.51%) € 6.20 € 341/€ 18,718
Folic acid 30 30 2,225 2,180 (97.98%) 45 (2.02%) 48 45 (93.75%) 3 (6.25%) € 5.64 € 254/€ 12,295
Ferritin 14 14 6,894 6,829 (99.06%) 65 (0.94%) 70 65 (92.86%) 5 (7.14%) € 6.23 € 405/€ 42,545
Transferrin 14 14 5,982 5,916 (98.90%) 66 (1.10%) 71 66 (92.96%) 5 (7.04%) € 4.24 € 280/€ 25,084
Iron 14 14 6,228 6,173 (99.12%) 55 (0.88%) 77 55 (71.43%) 22 (28.57%) € 2.26 € 124/€ 13,951
ESR 7 7 7,228 7,128 (98.62%) 100 (1.38%) 108 100 (92.59%) 8 (7.41%) € 1.92 € 192/€ 13,686
CRP 1 5 21,298 21,119 (99.16%) 179 (0.84%) 245 179 (73.06%) 66 (26.94%) € 4.06 € 727/€ 85,743
AST 1 2 6,354 6,341 (99.80% 13 (0.20%) 20 13 (65.00%) 7 (35.00%) € 1.80 € 23/€ 11,414
ALT 1 2 20,825 20,764 (99.71%) 61 (0.29%) 87 61 (70.11%) 26 (29.89%) € 1.90 € 116/€ 39,452
Total bilirubin 1 2 16,319 16,265 (99.67%) 54 (0.33%) 84 54 (64.29%) 30 (35.71%) € 1.49 € 80/€ 24,235
Conjugated bilirubin 1 2 1,749 1,745 (99.77%) 4 (0.23%) 6 4 (66.67%) 2 (33.33%) € 1.49 € 6/€ 2,600
LDH 7 14 14,889 13,852 (93.04%) 1,037 (6.96%) 1,124 1,037 (92.26%) 87 (7.74%) € 1.81 € 1,877/€ 25,072
Amylase 1 7 10,886 10,825 (99.44%) 61 (0.56%) 87 61 (70.11%) 26 (29.89%) € 2.21 € 135/€ 23,923
Free T4 30 30 7,625 7,489 (98.22%) 136 (1.78%) 261 136 (52.11%) 125 (47.89%) € 5.18 € 704/€ 38,793
T3 30 30 1,217 1,174 (96.47%) 43 (3.53%) 63 43 (68.25%) 20 (31.75%) € 6.93 € 298/€ 7,748
HbA1c 30 30 13,717 13,275 (96.78%) 442 (3.22%) 479 442 (92.28%) 37 (7.72%) € 6.10 € 2,696/€ 8,136
Creatinine 1 3 43,258 43,009 (99.42%) 249 (0.58%) 305 249 (81.64%) 56 (18.36%) € 1.64 € 408/€ 70,535
Triglycerides 5 30 6,946 6,917 (99.58%) 29 (0.42%) 326 29 (8.90%) 297 (91.10%) € 2.41 € 70/€ 16,670
HDL-cholesterol 30 30 6,901 6,873 (99.59%) 28 (0.41%) 45 28 (62.22%) 17 (37.74%) € 2.30 € 64/€ 15,808
Cholesterol 30 30 7,147 7,114 (99.54%) 33 (0.46%) 53 33 (62.26%) 20 (37.74%) € 1.72 € 56/€ 12,236
NT-proBNP 30 30 310 294 (94.84%) 16 (5.16%) 25 16 (64.00%) 9 (36.00%) € 15.67 € 251/€ 4,606
PSA 14 14 644 638 (99.07%) 6 (0.93%) 11 6 (54.55%) 5 (45.45%) € 6.43 € 39/€ 4,102
CEA 14 14 1,144 1,139 (99.56%) 5 (0.44%) 6 5 (83.33%) 1 (16.67%) € 7.83 € 39/€ 8,918
CA 125 14 14 321 318 (99.07%) 3 (0.93%) 3 3 (100.00%) 0 (0.00%) € 12.72 € 38/€ 4,045
CA 15.3 14 14 741 736 (99.33%) 5 (0.67%) 7 5 (71.43%) 2 (28.57%) € 12.72 € 64/€ 9,362
Beta HCG 14 14 210 208 (99.05%) 2 (0.95%) 3 2 (66.67%) 1 (33.33%) € 9.01 € 19/€ 1,874
IgG 365b 365b 2,255 1,996 (88.51%) 259 (11.49%) 282 259 (91.84%) 23 (8.16%) € 5.57 € 1,443/€ 11,118
IgM 365b 365b 2,124 1,921 (90.44%) 203 (9.56%) 206 203 (98.54%) 3 (1.46%) € 5.57 € 1,821/€ 10,700
Total 218,511 215,257 (98.51%) 3,254 (1.49%) 4,159 3,254 (78.24%) 905 (21.76%) 11,880/636,598
  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase; beta HCG, beta human chorionic gonadotropin; CA 125, cancer antigen 125; CA 15.3, cancer antigen 15.3; CEA, carcinoembryonic antigen; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; free T4, free thyroxine; HbA1c, haemoglobin A1C; HDL-cholesterol, high-density lipoprotein cholesterol; IgG, immunoglobulin G; IgM, immunoglobulin M; LDH, lactic dehydrogenase; MRI, minimum retesting interval; NT-proBNP, N-terminal fragment of probrain natriuretic peptide; PSA, prostate specific antigen; T3, triiodothyronine. Blocked tests due to MRI alerts are both described as “number of blocked tests” and as “honored MRI alerts”. aNational NZA rates, 2019 [12]; b365 days, if earlier result was in reference range.

Data collection and analysis

Data was extracted from the LIMS. First, all laboratory tests ordered for adult patients were included from the period between July 13th 2017 and December 31st 2019. Second, patients younger than 18 years old were excluded. Third, to select only orders from the department of internal medicine, the orders were sorted by wards and requesting physicians. Only wards and outpatient clinics were included where patients from the department of internal medicine are treated regularly. Also, only order requests from physicians of the department of internal medicine were included. Laboratory tests with less than 100 requests during the study period were excluded, namely alpha-1 antitrypsin, anti-CCP and alpha fetoprotein.

The primary outcome was percentages of tests ordered and barred as a result of MRIs. Secondary outcomes were financial savings calculated based on the national price ratings (NZA rates) [12]. Data analysis were performed using Microsoft Excel 2016 and IBM SPSS Statistics for Windows, version 26.0. Proportions of requested and performed tests were described as absolute number and percentage.

Results

After excluding tests with less than 100 requests during July 13th 2017 and December 31st 2019, 28 laboratory tests remained. In total, 218,511 requests of these tests were ordered during the study period by the department of internal medicine. Most of these requests were made in the outpatient clinics (72.98%), and a smaller amount at the emergency department (18.87%) and inpatient clinics (8.15%). The day care unit is included in the inpatient clinics, and dialysis unit included in the outpatient clinics. In the day care unit, patients are treated with chemotherapy, blood transfusion or other medications during the day and are discharged in the evening.

MRI alerts were reported in 4,159 tests, corresponding with 1.90% of the test requests. Physicians overruled these MRI alerts in 21.76% of the alerts and 78.24% of the MRI alerts were honored. 3,254 test requests out of a total of 218,511 (1.49%) were barred due to MRI implementation. Table 1 shows the MRI alerts and barred tests sorted by specific laboratory test, combined with the financial costs. Immunoglobulins, LDH and NT-proBNP had the highest percentage of blocked tests, whereas liver biochemical tests had the lowest percentage. Figure 1 presents an histogram with the percentage of blocked tests for all evaluated tests. Most of the barred test requests were ordered at the outpatient clinics (59.99%, 1952 test orders), compared to 16% (521 orders) at the emergency department and 24% (781 orders) at the inpatient clinics. The distribution of barred tests over the different locations in the hospital is illustrated in Figure 2.

Figure 1: 
Blocked tests due to MRIs (percentage of requested tests).
Figure 1:

Blocked tests due to MRIs (percentage of requested tests).

Figure 2: 
Distribution of tests between outpatient clinics, inpatient clinics and the emergency department (ED). Day care units are included in the inpatient care, and dialysis unit is included in the outpatient care.
Figure 2:

Distribution of tests between outpatient clinics, inpatient clinics and the emergency department (ED). Day care units are included in the inpatient care, and dialysis unit is included in the outpatient care.

The percentage of overruling MRIs was scattered between 0.00 and 91.10%, as shown in Table 1. Overruling MRIs was most common with regards to triglycerides, T4, PSA and HDL.

During the almost 30-month period evaluated in this study, the financial savings for the department of internal medicine due to the implementation of MRIs for 28 laboratory tests (see Table 1) was 11,880 euros on a total amount of 636,598 euros for all performed tests.

Discussion

This study evaluates the effect of implementing minimum retest intervals to reduce inappropriate laboratory test requests. Overall, the benefits of these MRI alerts on the amount of tests and financial savings are small. Only 1.49% of the test requests were barred as a result of implementing MRI alerts.

Contrary to previous studies, we observed only a small effect on the amount of tests by implementing MRIs. A 2020 review reported an average of 10.6% cancelled tests in 31 included studies in the period 2000–2020 [11]. However, a few other studies reported a limited effectiveness of MRIs. Pema et al. described a 3.18% cancellation rate of requested tests and Lapic et al. a 1.9% reduction of requested tests [1314]. A previous study in the Netherlands, the only Dutch study about this topic in the past, reported a proportion of 0.56% barred tests and 0.33% financial saving of total testing costs in line with our study [7]. These concurrent smaller effects of MRIs in the Netherlands may be explained by an already existing awareness of appropriate laboratory test utilization in the Netherlands. Compared to approximately 2% worldwide, only 0.5% of total health care budget is spend on IVD in the Netherlands and this is one of the lowest ratings in the world [2]. A striking difference between the Netherlands and other countries is the organization of laboratory diagnostics. In contrast to other countries, medical laboratories in the Netherlands are relatively small, mostly located in the hospital and collaborate with hospital staff on a daily basis. Therefore, clinical chemists are accessible for consultation by physicians and actively participate in multidisciplinary consultation. These interactive organization of clinical chemistry presumably leads to more awareness of appropriate laboratory test utilization, a diagnostic process that is more adjusted to an individual patient and is less driven by financial motives.

Another possible explanation for the different effects of MRIs compared to previous studies, is the various time intervals that are used for implementation of MRIs. The recommendations of the Association of Clinical Biochemistry and Laboratory Medicine for MRIs depend on the (suspected) diagnosis and previous results of an individual patient [9]. We implemented MRIs for all patients, inpatient and outpatient clinics separately. Therefore, comparison with these recommendations is complex. The various time intervals in previous studies, as reported in the review of Lang, impede the interpretation of these study results in context to each other [11]. Lapic et al. observed the effects of MRIs implemented in inpatient clinics and reported similar results as our study, but they defined overall longer time intervals than in our study (range of 1–30 days longer). Only IgG and lipogram test profile had longer time intervals in our study [14].

Overall, some laboratory tests have a shorter time interval while other tests have a longer interval. When narrowing this time interval, the proportion of barred tests will probably increase. However, when implementing MRIs, narrowing this time interval could also lead to more overruling of the MRIs. In our study, 21.76% of the MRI alerts were overruled by the physicians. These findings suggest smaller time intervals may not lead to positive effects on appropriate laboratory test utilization and may cause irritation to physicians and alert fatigue. Moreover, MRIs should prevent unnecessary test repeats and when overruling occurs frequently, the question is in which extent these were unnecessary test requests.

In addition, the possibility to overrule a MRI also affects the cancellation rate of requested tests. MRIs can be implemented as a soft block or hard block intervention, based on the additional effort necessary to overrule the MRI. An example of a soft block intervention is an alert which notifies the ordering physician that the test is probably not necessary, but the physician can still order the test. In case of a hard block intervention, the ordering physician can only overrule the MRI by making a phone call to the laboratory, for example. Procop et al. compared these two kind of interventions and concluded that a hard block was significantly more effective than an alert only [15]. According to this definition, we implemented hard blocking MRIs in our study. Lapic et al. also described limited effectiveness of MRIs, but they implemented soft blocking MRIs [14]. However, two of the other studies which reported limited effectiveness of MRIs had also implemented hard blocking MRIs [7, 13].

Differences between the outcome of our study and other studies could also be related to the clinical setting. Both our and the previous Dutch study were conducted in a general care and teaching hospital and showed similar results. Studies on MRI in primary or tertiary care may show different results. Pellicer et al. described a successful effect of hard blocking MRIs as a gate keeping system to reduce test requests for anti-thyroblobulin and anti-thyroid peroxidase antibodies in primary care, while no change in trend was achieved in specialized care [16]. It could also be assumed that longer time intervals could be more effective in the primary care, without a rise in overruling MRIs or an increase in underutilization, based on a different patient population with less complex diseases than in a hospital setting. Different clinical settings require different time intervals of MRIs.

A major strength of this study is that we analyzed the effect of MRI implementation for several frequently ordered laboratory tests, in combination with a long study period of almost 30 months. In addition, we evaluated the effect of MRIs in a general care and teaching hospital. The combination of these factors distinguishes this study from several previous studies and is therefore relevant for many hospitals in different settings.

This study has a few limitations. First, the MRIs were implemented as part of a study to reduce unnecessary laboratory testing and was combined with other interventions like education and feedback. After implementing this combination of interventions an average reduction of 11% in laboratory test volume was accomplished in the four participating hospitals [4]. Therefore, it was not possible to measure the effect of MRIs alone. By reporting only in proportions, a decrease in total laboratory testing due to these interventions had no influence on our outcomes. Nevertheless, an increased awareness of appropriate testing could have caused less test repeats during the time period of the MRIs and less barred test requests. For example, during this previous study awareness was created through education and changes in order systems for AST testing and this resulted in a significant decrease in AST orders. The indications of other laboratory tests like CRP and ESR were also discussed during this previous study. Consequently, it is possible that this created awareness have led to a relatively low effect of MRIs in this hospital.

Second, we only analyzed the department of internal medicine due to various implementation dates in each individual department. The effect of MRIs was potential bigger in other departments, because in other departments there were no other interventions carried out. On the other hand, most of the laboratory tests are ordered by the department of internal medicine. An earlier study about the differences in inappropriate repeat testing between specialties, described the highest ratio of inappropriate repeat testing in surgical science specialties while the highest volume of inappropriate repeat testing was ordered by specialties from clinical medical science (internal medicine included) [17].

Future research on this topic is necessary to study the effect of MRIs on creating awareness of appropriate laboratory testing. This awareness is difficult to measure due to different factors that can affect behavior, but the influence of MRIs is potentially much bigger than on the amount of test requests and cost savings. The previously described RODEO project, focusing on reducing inappropriate laboratory testing, also led to a significant decrease in volume of radiology, nuclear medicine or microbiology tests in three of the four participating hospitals [4]. This finding underscores our hypothesis that interventions such as MRIs have potential more effect than we can measure in retrospective studies due to changes in the behavior of physicians induced by the implementation of MRIs. Furthermore, we only calculated the direct cost reduction related to the number of barred tests measured. Less false-positive test results could have much bigger impact besides the direct laboratory-related costs.

In conclusion, the effect of implementing MRIs on the amount of laboratory testing and direct financial savings is limited in our study. However, MRI alerts offer a continue reminder for physicians to use diagnostics appropriately and can be used to create awareness. The use of MRIs should be considered to improve the appropriate use of laboratory tests, but the potential impact of these alerts in each hospital strongly depends on the overuse of laboratory testing before implementation, the position of the laboratory in the hospital and the clinical care setting.


Corresponding author: Prof. Robert de Jonge, PhD, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117 1081 HV, Amsterdam, The Netherlands, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The Medical Ethics Review Committee of VU University Medical Center waived the review of this study as the Medical Research Human Subjects Act did not apply to this study (IRB number: IRB00002991; case: 2020.0716).

References

1. Zhi, M, Ding, EL, Theisen-Toupal, J, Whelan, J, Arnaout, R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013;8. https://doi.org/10.1371/journal.pone.0078962.Search in Google Scholar PubMed PubMed Central

2. Global outlook on the in vitro diagnostics industry opportunities and challenges [Internet]. [cited 2022 Jun 21]. Available from: https://www.iqvia.com/library/white-papers/global-outlook-on-the-in-vitro-diagnostics-industry.Search in Google Scholar

3. Van Walraven, C, Raymond, M. Population-based study of repeat laboratory testing. Clin Chem 2003;49:1997–2005. https://doi.org/10.1373/clinchem.2003.021220.Search in Google Scholar PubMed

4. Bindraban, RS, Van Beneden, M, Kramer, MHH, Van Solinge, WW, Van De Ven, PM, Naaktgeboren, CA, et al.. Association of a multifaceted intervention with ordering of unnecessary laboratory tests among caregivers in internal medicine departments. JAMA Netw Open 2019;2. https://doi.org/10.1001/jamanetworkopen.2019.7577.Search in Google Scholar PubMed PubMed Central

5. Lillo, S, Larsen, TR, Pennerup, L, Antonsen, S. The impact of interventions applied in primary care to optimize the use of laboratory tests: a systematic review. Clin Chem Lab Med 2021;59:1336–52.10.1515/cclm-2020-1734Search in Google Scholar PubMed

6. Smit, I, Zemlin, AE, Erasmus, RT. Demand management: an audit of chemical pathology test rejections by an electronic gate-keeping system at an academic hospital in Cape Town. Ann Clin Biochem 2015;52:481–7. https://doi.org/10.1177/0004563214567688.Search in Google Scholar PubMed

7. Janssens, PMW, Wasser, G. Managing laboratory test ordering through test frequency filtering. Clin Chem Lab Med 2013;51:1207–15. https://doi.org/10.1515/cclm-2012-0841.Search in Google Scholar PubMed

8. Kilinçarslan, MG, Sahin, EM, Korkmazer, B. Prevalence and associated factors of inappropriate repeat test. Postgrad Med 2019;95:596–600. https://doi.org/10.1136/postgradmedj-2019-136696.Search in Google Scholar PubMed

9. Lang, TF. National minimum re-testing intervals project: a final report detailing consensus recommendations for minimum re-testing intervals for use in clinical biochemistry. London: Association for Clinical Biochemistry; 2013: 2012 p.Search in Google Scholar

10. Lang, T. Laboratory demand management of repetitive testing – time for harmonisation and an evidenced based approach. Clin Chem Lab Med 2013;51:1139–40. https://doi.org/10.1515/cclm-2013-0063.Search in Google Scholar PubMed

11. Lang, T. Minimum retesting intervals in practice: 10 years experience. Clin Chem Lab Med 2021;59:39–50.10.1515/cclm-2020-0660Search in Google Scholar PubMed

12. NZA Rates 2019 [Internet] [cited 2022 Jun 21]. Available from: https://puc.overheid.nl/nza/doc/PUC_236092_22/1/.Search in Google Scholar

13. Pema, AK, Kiabilua, O, Pillay, TS. Demand management by electronic gatekeeping of test requests does not influence requesting behaviour or save costs dramatically. Ann Clin Biochem 2018;55:244–53. https://doi.org/10.1177/0004563217707980.Search in Google Scholar PubMed

14. Lapić, I, Rogić, D, Fuček, M, Galović, R. Effectiveness of minimum retesting intervals in managing repetitive laboratortesting: experience from a Croatian university hospital. Biochem Med 2019;29. https://doi.org/10.11613/bm.2019.030705.Search in Google Scholar PubMed PubMed Central

15. Procop, GW, Keating, C, Stagno, P, Kottke-Marchant, K, Partin, M, Tuttle, R, et al.. Reducing duplicate testing: a comparison of two clinical decision support tools. Am J Clin Pathol 2015;143:623–6. https://doi.org/10.1309/ajcpjoj3hkebd3tu.Search in Google Scholar PubMed

16. Pellicer, PS, Tamayo, RG, López, VN. Reducing test request for anti-thyroglobulin and anti-thyroid peroxidase antibodies: trends before and after interventions based on rejection rules and profile management. Biochem Med 2018;28:1–7. https://doi.org/10.11613/bm.2018.030709.Search in Google Scholar PubMed PubMed Central

17. Kilincarslan, MG, Sahin, EM. Who repeats more laboratory tests inappropriately? Surgeons versus physicians. Int J Risk Saf Med 2021;32:219–27. https://doi.org/10.3233/jrs-200065.Search in Google Scholar PubMed

Received: 2022-09-22
Accepted: 2022-12-01
Published Online: 2022-12-19
Published in Print: 2023-02-23

© 2022 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-0946/html
Scroll to top button